Eric
Lindenfeld

JUUL and Altria. Prosecuted Minnesota’s case against JUUL and Altria through three weeks of trial, culminating in a $60.5 million settlement.

Opioids in California. Prosecuted state and federal opioid claims against Teva, Allergan, and Walgreens, developing litigation strategy for major trial proceedings. The litigation produced landmark rulings and settlements.

Opioids in Ohio. Developed legal strategy for government plaintiffs in the first federal opioid MDL bellwether proceedings against major distributors and Teva, coordinating complex legal issues across the national litigation.

Abilify. Prosecuted claims over compulsive gambling and other compulsive behaviors in nationwide Abilify litigation that resolved through a confidential global settlement.

Benicar. Represented patients in the Benicar litigation over severe intestinal injuries, which resolved through a $358 million global settlement.

Stryker. Represented patients injured by defective hip implants in coordinated national litigation.

Farxiga. Represented patients pursuing diabetic ketoacidosis claims against AstraZeneca and Bristol-Myers Squibb in the Farxiga MDL.

Social media. Represented Tribal Nations pursuing claims against major platforms over addiction and harms to children.

Sexual abuse. Represented survivors in litigation against churches, schools, and camps.

3M aerosol dusters. Prosecuted complex product-liability claims against 3M arising from inhalant misuse, shaping dispositive strategy and preparing the cases for trial.

Secured credit and noteholder enforcement. Established liability for secured noteholders enforcing more than $100 million in accelerated obligations and defeated efforts to assert additional counterclaims and third-party claims. The litigation subsequently produced a damages ruling exceeding $108 million.

Bitcoin investment products. Defeated summary judgment in litigation over a bitcoin investment-product venture involving claims exceeding $100 million, preserving all of the plaintiff’s claims for trial.

Commercial lending arbitration. Prosecuted a commercial lender’s claims seeking more than $100 million in arbitration arising from a substantial commercial-credit dispute and its underlying financing arrangements.

Corporate fraud and fiduciary duties. Prosecuted claims seeking more than $30 million for a technology company and its founder arising from alleged self-dealing, fraudulent financing arrangements, and diversion of corporate assets.

Cross-border finance and discovery. Litigated contested Section 1782 proceedings for an investment fund in connection with Irish High Court litigation over secured lending, refinancing, and receivership, including third-party subpoenas and the use of evidence in foreign proceedings.

Guaranties and receiverships. Litigated guaranty enforcement and contested receivership proceedings, addressing contractual enforceability and the preservation of issues for appellate review.

Corporate director defense. Defended a corporate director against federal fraud, civil RICO, and related claims, advancing personal-jurisdiction and pleading challenges. The court dismissed the claims against the director for lack of personal jurisdiction, with leave to amend.

Medical-device litigation and investigations. Defended officers and directors in medical-device litigation and parallel government investigations involving complex corporate, factual, and regulatory issues.

Specialty finance. Litigated complex investment and contract disputes for a specialty finance company involving financial arrangements and the enforcement of negotiated obligations.

Defamation, online speech, and privacy. Prosecuted and defended defamation, tortious-interference, and online-privacy claims, including pro bono matters. Litigated statutory protections for public advocacy and online speech.

Federal individual and business tax returns. Litigated and settled claims arising from significant errors in federal individual and business income tax returns.

Missed elections and filing failures. Secured substantial settlements in multiple state and federal actions involving missed tax elections and improper or untimely filings.

Executive trade secrets. Represented a C-suite private equity executive in trade-secret litigation.

Non-compete disputes. Represented an investor in litigation over a non-compete covenant.

Age discrimination. Represented a client in age-discrimination litigation.

Religious and sex discrimination. Represented clients in federal and state litigation involving religious and sex discrimination.

Severance and restrictive covenants. Negotiated severance agreements and non-compete provisions.

Inhalant injuries. Represented catastrophically injured bystanders in Minnesota litigation against 3M.

Severe burns. Represented an individual severely burned by hair-drying products.

Paralysis. Represented an individual rendered paraplegic after being struck by a truck.

Hospital injuries. Represented a pregnant individual seriously injured in a hospital fall.

Car accidents and falls. Represented plaintiffs catastrophically injured in collisions and falls.

Represented patients in medical-malpractice litigation involving serious injury and complex questions of medical causation.

His scholarship on medical malpractice has been cited by 27 state attorneys general in an amicus brief to the U.S. Supreme Court.

Toxic exposure. Coordinated national defense proceedings involving alleged industrial exposures and scientific evidence across multiple jurisdictions.